Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury
Abstract
Stroke is a complex disease that may involve oxidative stress-related pathways in its pathogenesis. The nuclear factor erythroid-2-related factor 2/antioxidant response element (Nrf2/ARE) pathway plays an important role in inducing phase II detoxifying enzymes and antioxidant proteins and thus has been considered a potential target for neuroprotection in stroke. The aim of the present study was to determine whether eriodictyol-7-O-glucoside (E7G), a novel Nrf2 activator, can protect against cerebral ischemic injury and to understand the role of the Nrf2/ARE pathway in neuroprotection. In primary cultured astrocytes, E7G increased the nuclear localization of Nrf2 and induced the expression of the Nrf2/ARE-dependent genes. Exposure of astrocytes to E7G provided protection against oxygen and glucose deprivation (OGD)-induced oxidative insult. The protective effect of E7G was abolished by RNA interference-mediated knockdown of Nrf2 expression. In vivo administration of E7G in a rat model of focal cerebral ischemia significantly reduced the amount of brain damage and ameliorated neurological deficits. These data demonstrate that activation of Nrf2/ARE signaling by E7G is directly associated with its neuroprotection against oxidative stress-induced ischemic injury and suggest that targeting the Nrf2/ARE pathway may be a promising approach for therapeutic intervention in stroke. - Highlights: • E7G activates Nrf2 in astrocytes.more »
- Authors:
-
- Department of Pharmacology, School of Medicine, Shandong University, Jinan 250012 (China)
- Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, Jinan 250012 (China)
- Health Science Center, Paul L. Foster School of Medicine, Texas Tech University, El Paso, TX, 79905 (United States)
- Publication Date:
- OSTI Identifier:
- 22285548
- Resource Type:
- Journal Article
- Journal Name:
- Toxicology and Applied Pharmacology
- Additional Journal Information:
- Journal Volume: 273; Journal Issue: 3; Other Information: Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); Journal ID: ISSN 0041-008X
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES; ANTIOXIDANTS; APOPTOSIS; BRAIN; CEREBRAL ARTERIES; GLUCOSE; GLUTATHIONE; IN VIVO; INJURIES; ISCHEMIA; LIGASES; OXIDATION; OXYGEN; PATHOGENESIS; RATS; RNA
Citation Formats
Jing, Xu, Ren, Dongmei, Wei, Xinbing, Shi, Huanying, Zhang, Xiumei, Perez, Ruth G., Lou, Haiyan, and Lou, Hongxiang. Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury. United States: N. p., 2013.
Web. doi:10.1016/J.TAAP.2013.10.018.
Jing, Xu, Ren, Dongmei, Wei, Xinbing, Shi, Huanying, Zhang, Xiumei, Perez, Ruth G., Lou, Haiyan, & Lou, Hongxiang. Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury. United States. https://doi.org/10.1016/J.TAAP.2013.10.018
Jing, Xu, Ren, Dongmei, Wei, Xinbing, Shi, Huanying, Zhang, Xiumei, Perez, Ruth G., Lou, Haiyan, and Lou, Hongxiang. Sun .
"Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury". United States. https://doi.org/10.1016/J.TAAP.2013.10.018.
@article{osti_22285548,
title = {Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury},
author = {Jing, Xu and Ren, Dongmei and Wei, Xinbing and Shi, Huanying and Zhang, Xiumei and Perez, Ruth G. and Lou, Haiyan and Lou, Hongxiang},
abstractNote = {Stroke is a complex disease that may involve oxidative stress-related pathways in its pathogenesis. The nuclear factor erythroid-2-related factor 2/antioxidant response element (Nrf2/ARE) pathway plays an important role in inducing phase II detoxifying enzymes and antioxidant proteins and thus has been considered a potential target for neuroprotection in stroke. The aim of the present study was to determine whether eriodictyol-7-O-glucoside (E7G), a novel Nrf2 activator, can protect against cerebral ischemic injury and to understand the role of the Nrf2/ARE pathway in neuroprotection. In primary cultured astrocytes, E7G increased the nuclear localization of Nrf2 and induced the expression of the Nrf2/ARE-dependent genes. Exposure of astrocytes to E7G provided protection against oxygen and glucose deprivation (OGD)-induced oxidative insult. The protective effect of E7G was abolished by RNA interference-mediated knockdown of Nrf2 expression. In vivo administration of E7G in a rat model of focal cerebral ischemia significantly reduced the amount of brain damage and ameliorated neurological deficits. These data demonstrate that activation of Nrf2/ARE signaling by E7G is directly associated with its neuroprotection against oxidative stress-induced ischemic injury and suggest that targeting the Nrf2/ARE pathway may be a promising approach for therapeutic intervention in stroke. - Highlights: • E7G activates Nrf2 in astrocytes. • E7G stimulates expression of Nrf2-mediated cytoprotective proteins in astrocytes. • E7G protects astrocytes against OGD-induced cell death and apoptosis. • The neuroprotective effect of E7G involves the Nrf2/ARE pathway. • E7G protects rats against cerebral ischemic injury.},
doi = {10.1016/J.TAAP.2013.10.018},
url = {https://www.osti.gov/biblio/22285548},
journal = {Toxicology and Applied Pharmacology},
issn = {0041-008X},
number = 3,
volume = 273,
place = {United States},
year = {2013},
month = {12}
}